Fatal angioedema induced by angiotensin conversion enzyme (ACE) inhibitors

Simple item page
dc.contributor.authorTiemensma M.
dc.contributor.authorBurger E.H.
dc.contributor.authorDempers J.J.
dc.contributor.authorWadee S.A.
dc.date.accessioned2011-05-15T15:54:29Z
dc.date.available2011-05-15T15:54:29Z
dc.date.issued2010
dc.description.abstractACE inhibitors are often prescribed in the treatment of hypertension, heart failure and kidney disease. These drugs are on the Essential Drugs List, and are therefore used at primary to tertiary health care levels in South Africa. Angioedema is considered a rare, but potentially fatal side-effect of this agent, with a reported incidence of 0.1-0.2% worldwide.1 Its incidence in the South African population is, however, unknown.
dc.description.versionArticle
dc.identifier.citationSouth African Family Practice
dc.identifier.citation52
dc.identifier.citation3
dc.identifier.issn1726426X
dc.identifier.urihttp://hdl.handle.net/10019.1/9226
dc.titleFatal angioedema induced by angiotensin conversion enzyme (ACE) inhibitors
dc.typeArticle
Files
Collections
Stellenbosch University - Scopus Publications